690 — Uni-Bio Science Income Statement
0.000.00%
Last trade - 00:00- HK$597.12m
- HK$526.06m
- HK$586.21m
Annual income statement for Uni-Bio Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 353 | 440 | 485 | 553 | 586 |
| Cost of Revenue | |||||
| Gross Profit | 277 | 335 | 393 | 461 | 488 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 373 | 397 | 408 | 461 | 483 |
| Operating Profit | -19.5 | 43.7 | 76.7 | 92.4 | 103 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -20 | 43.3 | 75.9 | 91.2 | 102 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.6 | 38.5 | 70.9 | 82.8 | 93.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.6 | 38.5 | 70.9 | 82.8 | 93.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.6 | 38.5 | 70.9 | 82.8 | 93.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | 0.006 | 0.011 | 0.014 | 0.016 |
| Dividends per Share |